Market Place
Sourcing Support
All News #Library
Biotech
Alentis Strengthens Management Team With Key Appointments
12 Nov 2025 //
BUSINESSWIRE
Alentis Appoints Mark Pruzanski As CEO
15 Oct 2025 //
PHARMIWEB
Catalio bankrolls biotechs with $400M-plus fund
01 Jul 2025 //
FIERCE BIOTECH
Alentis Receives FDA Fast Track for ALE.P02 in CLDN1+ Solid Tumors
18 Nov 2024 //
BUSINESSWIRE
Novo Holdings, OrbiMed, Jeito lead $181M fundraise for ADC biotech
12 Nov 2024 //
FIERCE BIOTECH
Novo Holdings Co-Leads $181.4M Series D in Alentis for ADCs
12 Nov 2024 //
PR NEWSWIRE
Alentis Therapeutics Raises $181.4M for Anti-Claudin-1 ADCs
12 Nov 2024 //
BUSINESSWIRE
Alentis Gets FDA IND Clearance For Squamous Cancer Treatment
02 Oct 2024 //
BUSINESSWIRE
Alentis Doses Progressive Glomerulonephritis Patient in Ph 2 Trial of Lixudebart
05 Dec 2023 //
BUSINESSWIRE
Positive Results from Single Ascending Dose PI of ALE.F02 Targeting Claudin-1
09 Jan 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.